Showing results (821-830 of 3,150) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.
Neuro-Oncology|February 4, 2021
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO groupNorbert Galldiks, Maximilian Niyazi, Anca L Grosu, et al.
Neuro-Oncology|February 5, 2021
The impact of socioeconomic status (SES) on cognitive outcomes following radiotherapy for pediatric brain tumors: a prospective, longitudinal trialVictoria A Torres, Jason M Ashford, Evelyn Wright, et al.
Neuro-Oncology|January 9, 2022
Liquid biopsy in gliomas: A RANO review and proposals for clinical applicationsRiccardo Soffietti, Chetan Bettegowda, Ingo K Mellinghoff, et al.
Neuro-Oncology|December 29, 2021
Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg StudySarah Peters, Julien Merta, Laura Schmidt, et al.
Neuro-Oncology|December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutantEmmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Neuro-Oncology|June 10, 2011
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitorsMelissa M Singh, Christa A Manton, Krishna P Bhat, et al.
Neuro-Oncology|August 2, 2011
Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusionJayant Narang, Rajan Jain, Ali Syed Arbab, et al.
Neuro-Oncology|July 30, 2011
δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancyPablo A Valdés, Anthony Kim, Marco Brantsch, et al.
Neuro-Oncology|July 30, 2011
Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2Matthieu Peyre, Stephane Goutagny, Sandrine Imbeaud, et al.
Pageof 315